New Issue of Nature Biotechnology is Now Available
May 21, 2010
Nature Biotechnology (Volume 28, Number 5, May 2010) is now available by subscription only.
Articles Include:
- “Biotechs adjust to new landscape as US healthcare reform takes off” by Jeffrey L. Fox, 385-386.
- “Genetech, UCSF discover pact” by Jennifer Rohn, 386.
- “FDA crackdown on Genzyme” by Keith L. Carson, 388.
- “Chinese green light for GM rice and maize prompts outcry” by Hepeng Jia, 390-391.
- “How green biotech turned white and blue” Â by Lucas Laursen, 393-395.
- “Drug marketing and the new media” by Sarah Webb, 396-398.
- “GM crops and gender issues” by Arjunan Subramanian, Kerry Kirwan, David Pink and Matin Qaim, 404-406.
- “South-South entrepreneurial collaboration in health biotech” by Halla Thorsteinsdóttir, Christina C Melon, Monali Ray, Sharon Chakkalackal, Michelle Li, Jan E Cooper, Jennifer Chadder, Tirso W Saenz, Maria Carlota de Souza Paula, Wen Ke, Lexuan Li, Magdy A Madkour, Sahar Aly, Nefertiti El-Nikhely, Sachin Chaturvedi, Victor Konde, Abdallah S Daar and Peter A Singer, 407-416.
- “Open biotechnology: licenses needed” by Yann Joly, 417-419.
- “Research at the interface of industry, academia and regulatory science” by William B Mattes, Elizabeth Gribble Walker, Eric Abadie, Frank D Sistare, Jacky Vonderscher, Janet Woodcock and Raymond L Woosley, 432-433.
